Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease
Persistent severe symptoms that interfere with daily activities or lead to dehydration should prompt immediate medical consultation, as medication discontinuation or alternative treatments may be necessary
We accept In stock Ships today if ordered by 3 PM EST USA fulfillment COA on request 3rd-party tested 24 h dispatch Certificate of Analysis current lot Verified Batch / Lot # GP-20F2-2025 Test date June 6, 2026 Laboratory Freedom Diagnostics Identity / Purity (HPLC) 98.40% Mass confirmation (LC-MS) Match Endotoxin (LAL, USP ) 0.44 EU/mg Residual solvents (USP ) Pass Water content (KF) Pass Description Reviews BPC-157 10 mg Research Grade BPC-157 is a synthetic pentadecapeptide (often referred to as Body Protection Compound) widely studied in tissue-repair, gastrointestinal, and angiogenesis research models
At clinical doses under supervision, the most common side effects are mild nausea in the first week (typically resolves by day 7 to 10), injection site reactions (redness, minor swelling, localized soreness lasting 24 hours), and occasional transient fatigue or mild headache in the first few days
8 weeks (10 vials): 30 mL 3 bottles 12 weeks (19 vials): 57 mL 6 bottles 16 weeks (32 vials): 96 mL 10 bottles Alcohol Swabs One for the vial stopper + one for the injection site each day
